The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 18
- 18 new
- Median first-year cost
- $928,521
- $16,338,124 in all
- Institutions
- 15
- 18 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
6
6
5
1
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES2
- UNIVERSITY OF WASHINGTON2
- VANDERBILT UNIVERSITY MEDICAL CENTER2
- BAYLOR COLLEGE OF MEDICINE1
- BOSTON CHILDREN'S HOSPITAL1
and 10 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHG1 HGR-P (J2))5
- Special Emphasis Panel (ZHG1 HGR-T (J1))5
- Special Emphasis Panel (ZHG1 HGR-P (M2))4
- Special Emphasis Panel (ZHG1 HGR-P (O1))4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2024 | GEMINEA: Genomic Medicine for Individuals from East Africa1R01HG013425-01 | Kullo, Iftikhar J | MAYO CLINIC ROCHESTER, MN | First-year cost $847,553 | Study section ZHG1 |
| FY2023 | Applying Population Management Best Practices to Preventive Genomic Medicine1R01HG013021-01 | Knerr, Sarah | UNIVERSITY OF WASHINGTON, WA | First-year cost $949,489 | Study section ZHG1 |
| FY2023 | Fair Phenotype Annotation and Genomic Reinterpretation1R01HG013031-01 | Chung, Wendy KWang, KaiWeng, Chunhua | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $886,418 | Study section ZHG1 |
| FY2023 | Pharmacogenomics to Catalyze Decision Support in Oncology Care1R01HG012273-01A1 | O'Donnell, Peter Hugh | UNIVERSITY OF CHICAGO, IL | First-year cost $884,216 | Study section ZHG1 |
| FY2023 | Advancing the implementation of variant-level functional data into clinical databases and clinical practice1R01HG013025-01 | Starita, LeaStergachis, Andrew Ben | UNIVERSITY OF WASHINGTON, WA | First-year cost $826,192 | Study section ZHG1 |
| FY2023 | African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa1R01HG012284-01A1 | Lumaka Zola, Aime | CENTRE DE GENETIQUE HUMAINE | First-year cost $627,251 | Study section ZHG1 |
| FY2022 | Translating the Clinical Knowledge of Mendelian Diseases to Real-world EHR Data to Improve Identification of Undiagnosed Patients1R01HG012657-01 | Bastarache, LisaRuderfer, Douglas | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $1,027,598 | Study section ZHG1 |
| FY2022 | RESCUE: Rare Disease Detection and Escalation Support via a Learning Health System1R01HG012655-01 | Liu, Cong | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,019,964 | Study section ZHG1 |
| FY2022 | Rational Integration of Polygenic Risk Scores (RIPS)1R01HG012262-01 | Hao, JingPeterson, Joseph F.Veenstra, David L | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $999,221 | Study section ZHG1 |
| FY2022 | Age-based genomic screening in newborns, infants, and children: a novel paradigm in public health genomics1R01HG012271-01A1 | Berg, Jonathan SMilko, Laura Vogel | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $933,000 | Study section ZHG1 |
| FY2022 | Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System1R01HG012670-01 | Nathanson, Katherine L.Ritchie, Marylyn DSchnoll, Robert Adam | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $924,042 | Study section ZHG1 |
| FY2022 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care1R01HG012286-01 | Marth, Gabor TTristani-Firouzi, Martin | UNIVERSITY OF UTAH, UT | First-year cost $914,518 | Study section ZHG1 |
| FY2021 | VIGOR: Virtual Genome Center for Infant Health1R01HG011798-01A1 | Agrawal, Pankaj BParker, Margaret Graham KemperYu, Timothy Wei-Wen | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $1,097,885 | Study section ZHG1 |
| FY2021 | Real-time genetic diagnosis at the point of care1R01HG011799-01 | Williams, Marc S. | GEISINGER CLINIC, PA | First-year cost $975,703 | Study section ZHG1 |
| FY2021 | Genomic medicine and gene function implementation for an underserved population1R01HG011795-01 | Bellen, Hugo JWangler, Michael Francis | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $962,213 | Study section ZHG1 |
| FY2021 | BUILDING THE EVIDENCE BASE FOR APPROPRIATE AND EFFICIENT IMPLEMENTATION OF EMERGING GENOMIC TESTS FOR DISEASE MANAGEMENT AND SCREENING1R01HG011792-01 | Phillips, Kathryn A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $953,132 | Study section ZHG1 |
| FY2021 | Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings1R01HG011794-01 | Orlando, Lori Ann | DUKE UNIVERSITY, NC | First-year cost $759,738 | Study section ZHG1 |
| FY2021 | Preemptive pharmacogenetic testing in medically underserved populations1R01HG011800-01 | Duarte, Julio David | UNIVERSITY OF FLORIDA, FL | First-year cost $749,991 | Study section ZHG1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.